V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012398 | 330005022 | 1.74 | null | Palliative (P) | 2016-06-30 | 2016-09-24 | Methotrexate intrathecal | N | N | 330015996 | METHOTREXATE INTRATHECAL |
| 330012399 | 330005030 | 1.04 | 66.3 | Curative (C) | 2014-07-08 | 2014-07-08 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330016049 | CAV |
| 330012400 | 330008755 | 1.64 | 70 | Disease modification (D) | 2019-03-12 | 2019-03-26 | DA 3+8 | N | null | 330016168 | VINBLASTINE |
| 330012401 | 330005044 | 1.72 | null | Palliative (P) | 2017-12-30 | 2017-12-30 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330016204 | LIPOSOMAL DOXORUBICIN |
| 330012402 | 330005047 | 1.51 | 18.4 | Disease modification (D) | null | 2015-11-10 | DA 3 + 10 | null | null | 330016224 | VINBLASTINE |
| 330012403 | 330010744 | null | 69.4 | Neo-adjuvant (N) | 2017-03-03 | 2017-03-04 | VAC | Y | N | 330016238 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330012404 | 330005061 | 1.69 | 75.5 | Palliative (P) | 2018-07-25 | 2018-07-25 | Cisplatin + Etoposide po&iv 3 day | N | N | 330016340 | CAV |
| 330012405 | 330010751 | 0 | 14.3 | Palliative (P) | 2016-09-15 | 2016-09-21 | Cyclophosphamide + Topotecan | N | N | 330016407 | AZACITIDINE |
| 330012406 | 330005079 | null | 69.4 | Not known (9) | null | 2018-01-25 | Liposomal Doxorubicin 50mg/m2 | null | null | 330016585 | LIPOSOMAL DOXORUBICIN |
| 330012407 | 330008781 | 1.64 | 63.3 | Palliative (P) | 2016-08-12 | 2016-08-15 | Cisplatin + Doxorubicin | 02 | N | 330016671 | CISPLATIN + ETOPOSIDE |
| 330012408 | 330005104 | 1.79 | null | Palliative (P) | 2014-03-20 | 2014-03-20 | Cytarabine High Dose | N | N | 330016828 | CYTARABINE HIGH DOSE |
| 330012409 | 330005108 | 1.67 | 57 | Palliative (P) | 2014-11-02 | 2014-11-02 | Azacitidine | N | N | 330016918 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012410 | 330005110 | 1.72 | 89.7 | Curative (C) | 2017-07-21 | 2017-10-01 | EW EuroEwing 99 : VIDE | N | N | 330016923 | EURO-EWING |
| 330012411 | 330005114 | 1.7 | 59.3 | Curative (C) | 2014-04-23 | 2014-05-08 | Trabectedin | N | N | 330016960 | TRABECTEDIN |
| 330012412 | 330005119 | 1.5 | 79.4 | Palliative (P) | 2014-03-04 | 2014-03-04 | VAC | 02 | N | 330016972 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012413 | 330012843 | 1.77 | 22.55 | Palliative (P) | 2016-09-03 | 2017-08-01 | Docetaxel 75mg/m2 (21 day) | 2 | N | 330016977 | DOCETAXEL |
| 330012414 | 330005123 | null | null | Palliative (P) | 2017-09-30 | 2017-12-31 | Azacitidine | 02 | N | 330017013 | DA |
| 330012415 | 330005131 | 1.96 | 78.3 | Palliative (P) | 2015-12-17 | 2016-02-05 | Cytarabine High Dose | N | null | 330017052 | CYTARABINE HIGH DOSE |
| 330012416 | 330013319 | 1.49 | 59.4 | Palliative (P) | 2013-05-25 | 2013-11-27 | GemCarbo Days 1+8 | 02 | N | 330017086 | GEMCARBO |
| 330012417 | 330005140 | 1.8 | 49.9 | Palliative (P) | 2016-02-23 | 2016-02-23 | DA 3+8 | 02 | N | 330017162 | CISPLATIN + ETOPOSIDE |
| 330012418 | 330005142 | 1.56 | 37 | Palliative (P) | 2017-04-24 | 2017-07-26 | Trabectedin | N | N | 330017192 | TRABECTEDIN |
| 330012419 | 330005149 | 188 | 20.4 | Curative (C) | 2017-03-02 | 2017-03-02 | Cytarabine High Dose | N | N | 330017243 | CYTARABINE HIGH DOSE |
| 330012421 | 330005157 | 1.61 | 65.8 | Disease modification (D) | 2014-12-19 | 2014-12-29 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330017337 | LIPOSOMAL DOXORUBICIN |
| 330012422 | 330008821 | 1.57 | 65.4 | Palliative (P) | 2014-12-20 | 2014-12-20 | EW Rel Irinotecan & Temozolomide | 02 | null | 330017399 | IRINOTECAN + TEMOZOLOMIDE |
| 330012423 | 330005175 | 1.63 | null | Palliative (P) | 2015-08-27 | 2015-08-28 | NIVOLUMAB | N | N | 330017510 | CISPLATIN + DOXORUBICIN |
| 330012424 | 330005180 | 1.8 | 75.3 | Palliative (P) | 2014-12-01 | 2015-04-07 | EW EuroEwing 99 : VIDE | N | N | 330017544 | EURO-EWING |
| 330012426 | 330012499 | 1.54 | 59.4 | Palliative (P) | 2016-11-29 | 2017-03-05 | DA 3+8 | Y | N | 330017709 | VINBLASTINE |
| 330012427 | 330005203 | 1.78 | null | Palliative (P) | 2016-10-17 | 2017-01-29 | GemCarbo Days 1+8 | null | null | 330017807 | GEMCARBO |
| 330012428 | 330005206 | null | 70.5 | Palliative (P) | 2018-04-05 | 2018-07-24 | Docetaxel 75mg/m2 (21 day) | N | null | 330017809 | DOCETAXEL |
| 330012430 | 330005219 | 1.6 | 94.7 | Palliative (P) | 2016-03-02 | 2016-11-14 | Irinotecan + Temozolomide | 02 | N | 330017922 | IRINOTECAN + TEMOZOLOMIDE |
| 330012431 | 330011879 | 1.74 | 100 | Curative (C) | 2017-01-26 | 2017-01-29 | Temozolomide 150mg/m2 | N | N | 330018009 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012432 | 330005245 | 1.63 | null | Palliative (P) | 2016-08-26 | 2016-09-24 | Etoposide oral | null | null | 330018401 | ETOPOSIDE |
| 330012433 | 330008864 | null | 42 | Curative (C) | 2014-06-25 | 2014-06-25 | VAC | 02 | N | 330018542 | NIVOLUMAB |
| 330012434 | 330008870 | 1.77 | 78 | Palliative (P) | null | 2014-07-16 | EW EuroEwing 99 : VIDE | 02 | N | 330018705 | EURO-EWING |
| 330012435 | 330005269 | 1.66 | 22.55 | Palliative (P) | 2018-01-29 | 2018-01-31 | ETOPOSIDE | N | N | 330018777 | ETOPOSIDE |
| 330012437 | 330008876 | 0 | 31.3 | Curative (C) | 2017-04-29 | 2017-04-29 | ETOPOSIDE | N | N | 330018883 | ETOPOSIDE |
| 330012438 | 330008877 | 1.73 | 0 | Palliative (P) | 2016-06-10 | 2016-11-05 | Docetaxel | N | N | 330018923 | DOCETAXEL |
| 330012439 | 330005293 | 1.83 | null | Curative (C) | 2017-01-12 | 2017-01-15 | Cisplatin + Doxorubicin | 02 | Y | 330018990 | VINBLASTINE |
| 330012440 | 330005298 | 1.75 | 70.9 | Palliative (P) | 2018-06-27 | 2018-06-27 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 330019079 | TEMOZOLOMIDE |
| 330012441 | 330011890 | null | 8.4 | null | 2015-10-09 | 2015-10-13 | Cisplatin + Doxorubicin | 02 | N | 330019369 | CISPLATIN + DOXORUBICIN |
| 330012442 | 330011894 | 1.63 | 68.1 | Curative (C) | 2014-02-13 | 2014-03-16 | Methotrexate intrathecal | 2 | N | 330019528 | METHOTREXATE INTRATHECAL |
| 330012444 | 330005335 | null | 65 | Curative (C) | 2014-05-19 | 2015-04-28 | STS Rhabdo RMS 2005 Vin Cyclo | null | N | 330019624 | PEMBROLIZUMAB |
| 330012445 | 330005338 | 1.63 | null | Curative (C) | 2015-11-01 | 2015-12-21 | Doxorubicin + Gemcitabine | null | null | 330019627 | HYDROXYCARBAMIDE |
| 330012446 | 330005340 | 1.71 | 83 | Curative (C) | 2015-03-22 | 2016-05-03 | CYTARABINE + DAUNORUBICIN + ETOPOSIDE | N | N | 330019639 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330012447 | 330008913 | 1.92 | 91.9 | Palliative (P) | 2018-08-04 | 2018-08-06 | Dox + HD Mtx (post PAM) | 1 | N | 330019654 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330012448 | 330010834 | null | 47.8 | Neo-adjuvant (N) | null | 2014-02-09 | CISPLATIN + ETOPOSIDE + PACLITAXEL | null | N | 330019674 | PAC-E |
| 330012449 | 330005350 | null | 53.2 | null | 2015-08-05 | 2015-08-09 | BEP 5 Day | N | null | 330019675 | EP |
| 330012451 | 330005360 | null | 84.2 | Palliative (P) | 2015-10-24 | 2016-02-10 | Dacarbazine | 02 | null | 330019771 | IFOSFAMIDE |
| 330012452 | 330005364 | 0 | 71.1 | Palliative (P) | 2013-07-31 | 2013-09-07 | AML17 TRIAL | null | null | 330019784 | CVP R |
| 330012453 | 330005369 | null | 96.1 | Curative (C) | 2015-04-26 | 2015-05-03 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | Y | N | 330019807 | UKALL2014 |